Get started
Work

Abstract 4716: Therapeutic utility of EC359 for targeting oncogenic LIFR signaling in triple negative breast cancer

Year: 2019
Type: conference-abstract
DOI: 10.1158/1538-7445.am2019-4716
Authors: Suryavathi Viswanadhapalli, Mengxing Li, Yiliao Luo, Gangadhara R Sareddy, Bindu Santhamma, Mei Zhou, Shihong Ma, Rajni Sonavane, Uday P. Pratap, Kristin A. Altwegg, Annabel Chang, Alejandra Chávez-Riveros, Kalarickal V. Dileep, Kam Y. Zhang, Marek Bajda, Ganesh V. Raj, Andrew Brenner, Vijaya Manthati, Manjeet Rao, Rajeshwar R. Tekmal, Hareesh B. Nair, Klaus J. Nickisch, Ratna K. Vadlamudi
Institutions: The University of Texas at San Antonio Health Science Center, Evestra (United States), First People's Hospital of Xianyang, The University of Texas Southwestern Medical Center, RIKEN, RIKEN Center for Biosystems Dynamics Research, Jagiellonian University
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4233961547
Cites:
Cited by:
Related to: 10